NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ORF Genetics

ORF Genetics

Private
IcelandHealthcare & Life Scienceshttps://www.orfgenetics.com/

Last Round

VC Round

Sep 10, 2025

Total Funding Raised

$2.95M

Company Overview

ORF Genetics is a biotechnology company that develops and manufactures recombinant proteins, such as growth factors, in bioengineered barley plants for use in stem cell research, regenerative medicine, cultivated meat, and skincare.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

recombinant proteinsgrowth factorsmolecular farminganimal-free growth factorscultivated meatbarley expression systemcellular agriculturelab grown meatstem cell researchplant-made proteinsendotoxin-free proteinsregenerative medicinecytokinescell culture mediabiomanufacturingancillary materialsskincare ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ORF Genetics Comparables

Compare ORF Genetics with similar companies based on industry and business-model similarity.

ORF Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Biotech
86%
Core Biogenesis
85%
Ventria Bioscience
83%

ORF Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 10, 2025
GrantAug 1, 2020

Key People

Founding team and executive leadership

Berglind Ran Olafsdottir

CEO

Executive Team

ORF Genetics Investors

Notable investors and investment history

ORF Genetics investors
InvestorRounds
European CommissionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2025

    Monthly visitors grew 206% MoM, from 392 to 1.2K.

  • Feb 21, 2025

    Grew 16% QoQ, from 25 to 29 employees.

ORF Genetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ORF Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ORF Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersIceland
Employee Range26
Year Founded2001
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.